A detailed history of Options Solutions, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Options Solutions, LLC holds 13,716 shares of BMY stock, worth $548,502. This represents 0.43% of its overall portfolio holdings.

Number of Shares
13,716
Previous 14,909 8.0%
Holding current value
$548,502
Previous $764,000 2.75%
% of portfolio
0.43%
Previous 0.82%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $57,240 - $64,899
-1,193 Reduced 8.0%
13,716 $743,000
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $58,612 - $69,940
1,209 Added 8.82%
14,909 $764,000
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $76,452 - $84,888
1,200 Added 9.6%
13,700 $876,000
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $519,108 - $588,787
7,900 Added 171.74%
12,500 $866,000
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $6,848 - $8,109
-100 Reduced 2.13%
4,600 $330,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $611 - $361,148
4,700 New
4,700 $334,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Options Solutions, LLC Portfolio

Follow Options Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Options Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Options Solutions, LLC with notifications on news.